CAS: 2318-25-4; Ethyl 3-Ethoxy-3-Iminopropionate Hydrochloride

该化合物是有机合成中的一种多用途中间体,尤其因其在准备环环化合物和功能化酯方面的作用而得到重视;盐盐能增强稳定性和溶性,便利处理和储存;其反应的伊尼诺和酯群能够有效地参与凝聚,循环化和增加核生殖反应,使其在制药和农用化学研究中有用;乙氧组进一步调整再活性,在合成途径中提供选择性;该复合体的特点是高纯度和一贯性能,确保复合合成合成物的再生性能;其应用范围扩大到生物活性分子和精细化学品的开发.

结构式图片

相似化合物

10344-69-1 2225144-12-5 27317-59-5

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号64-17-5 乙醇 | CAS号105-56-6 氰乙酸乙酯 | CAS号111222-40-3 2-氨基-5-苯基-1H-吡咯... | CAS号50551-10-5 3-氨基-3-亚氨基丙酸乙酯 | CAS号2148-86-9 Ethyl (5,6-dime... | CAS号34570-17-7 丙二酰脒盐酸盐 | CAS号29182-42-1 2-(2-苯并噻唑)乙酸乙酯 | CAS号32002-24-7 3,3-二乙氧基丙烯酸乙酯 | CAS号7597-56-0 氨基甲酰乙酸乙酯 | CAS号75-00-3 氯乙烷 | CAS号6829-41-0 异亚硝基丙二酸二乙酯 | CAS号57508-48-2 3-脒基丙酸乙酯盐酸盐

合成工艺路线路线简述

    β-乙氧基-β-亚氨基丙酸乙酯置于氯化铵体系中,用 乙醇 用作溶剂,化学反应 16.0H,以84%的收率获得3-乙氧基-3-亚氨基丙酸乙酯盐酸盐
    参考文献: Biaryl Compounds Useful For The Treatment Of Human Diseases In Oncology,Neurology And Immunology[fr] Composés Biaryliques Utiles Pour Le Traitement De Maladies Humaines En Oncologie,Neurologie Et Immunologie
    标题: Biaryl Compounds Useful For The Treatment Of Human Diseases In Oncology,Neurology And Immunology[fr] Composés Biaryliques Utiles Pour Le Traitement De Maladies Humaines En Oncologie,Neurologie Et Immunologie
    摘要:本发明提供了作为bruton'S酪氨酸激酶抑制剂的化合物及其组合物,具有适用于同一目的的理想特性.

    海关参考信息

    专利信息


    专利号:US-8309540-B2
    优先权日:2006-10-24
    标 题:HCV NS3 protease inhibitors
    发明人:LIVERTON NIGEL J; VACCA JOSEPH P; MCCAULEY JOHN A; ROMANO JOSEPH J; RUDD MICHAEL T
    权利人:LIVERTON NIGEL J; VACCA JOSEPH P; MCCAULEY JOHN A; ROMANO JOSEPH J; RUDD MICHAEL T; MERCK SHARP & DOHME
    摘要:The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. (I)

    专利号:US-RE50050-E
    优先权日:2013-06-21
    标 题 :Pyrimidinedione compounds
    发明人:OSLOB JOHAN; ANDERSON ROBERT; AUBELE DANIELLE; EVANCHIK MARC; FOX JONATHAN CHARLES; KANE BRIAN; LU PUPING; MCDOWELL ROBERT; RODRIGUEZ HECTOR; SONG YONGHONG; SRAN ARVINDER
    权利人:MYOKARDIA INC
    摘要:Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.

    专利号:US-8927569-B2
    优先权日:2007-07-19
    标 题 :Macrocyclic compounds as antiviral agents
    发明人:HARPER STEVEN; SUMMA VINCENZO; LIVERTON NIGEL J; MCCAULEY JOHN A; BUTCHER JOHN W; DI FILIPPO MARCELLO; DI FRANCESCO MARIA EMILIA; FERRARA MARCO; ROMANO JOSEPH J; RUDD MICHAEL T
    权利人:HARPER STEVEN; SUMMA VINCENZO; LIVERTON NIGEL J; MCCAULEY JOHN A; BUTCHER JOHN W; DI FILIPPO MARCELLO; DI FRANCESCO MARIA EMILIA; FERRARA MARCO; ROMANO JOSEPH J; RUDD MICHAEL T; MERCK SHARP & DOHME
    摘要:A class of macrocyclic compounds of formula (I), wherein R 1 , R 3 , R 4 , R a , R b , A, Z, Y, X, M, W, n and m are defined herein, that are useful as inhibitors of viral proteases, particularly the hepatitis C virus (HCV) NS3 protease, are provided. Also provided are processes 5 for the synthesis and use of such macrocyclic compounds for treating or preventing HCV infection. Formula (I):

    专利号:US-2023383342-A1
    优先权日:2022-05-31
    标 题 :Compositions and methods for nucleic acid sequencing
    发明人:WU XIAOLIN; MCCAULEY PATRICK; DHARMARWARDANA MADUSHANI; NIRANTAR SAURABH; GOLYNSKIY MISHA; YANG XIANGYUAN; NEELAKANDAN RAMESH; MACKWORTH BENEDICT; ANASTASI CAROLE; KARUNAKARAN AATHAVAN; VESSERE GERY M; BRACHER DAVID
    权利人:ILLUMINA CAMBRIDGE LTD; ILLUMINA SINGAPORE PTE LTD; ILLUMINA INC; ILLUMINA SOFTWARE INC
    摘要:Embodiments of the present disclosure relate to kits, compositions, and methods for nucleic acid sequencing, for example, two-channel nucleic acid sequencing by synthesis using blue and green light excitation. In particular, unlabeled nucleotides for incorporation may be used in conjunction with affinity reagents containing detectable labels excitable by blue and/or green lights, for specific binding to each type of nucleotides incorporated.

    专利号:US-8377874-B2
    优先权日:2006-10-27
    标题 :HCV NS3 protease inhibitors
    发明人:LIVERTON NIGEL J; VACCA JOSEPH P; MCCAULEY JOHN A; RUDD MICHAEL T
    权利人:MERCK SHARP & DOHME; LIVERTON NIGEL J; VACCA JOSEPH P; MCCAULEY JOHN A; RUDD MICHAEL T
    摘要:The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

    专利号:US-4990515-A
    优先权日:1989-01-16
    标 题:Benzo[1,8]naphthyridine derivatives as antimicrobials
    发明人:ANTOINE MICHEL; BARREAU MICHEL; DESCONCLOIS JEAN-FRANCOIS; GIRARD PHILIPPE; PICAUT GUY
    权利人:BELLON LABOR SA ROGER
    摘要:New benzo[b][1,8]naphthyridine derivatives of general formula (I), in which R is a hydrogen atom or an alkyl, fluoroalkyl, cycloalkyl (3 to 6 C), alkoxy or alkylamino radical or an amine protective radical and either Hal is a fluorine, chlorine or bromine atom and R' is a hydrogen atom or Hal and R' are simultaneously fluorine atoms, their salts, their preparation and the compositions which contain them. These new products can be used as antimicrobial agents for topical application or as synthesis intermediates. (I)
    海门瑞一医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ruiyitech.cn
    企业联系电话:021-54718086👤
    📞海门瑞一医药科技有限公司 ⚠️参考联系方式
    联系人:余小姐
    电话:021-54718086

    传真:021-54711707
    邮箱:sales5@ruiyitech.com
    通信地址: 江苏海门大庆路19号
    邮编: 226100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏海门大庆路19号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Schnürch, M.; Hämmerle, J.; Stanetty, P., Science of Synthesis Knowledge Updates, (2010) 1, 170.
    摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 293.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知